Connect
MJA
MJA

The seroprevalence of antibodies to Japanese encephalitis virus in five New South Wales towns at high risk of infection, 2022

Keira M Glasgow and Kirsty Hope
Med J Aust 2024; 221 (8): . || doi: 10.5694/mja2.52454
Published online: 21 October 2024

In reply: On behalf of our co‐authors, we thank Islam and Seale for their interest in our article.1 We largely support the general sentiments of Islam and Seale.2 The seroprevalence survey that was the focus of our article was undertaken to support and guide the rapid public health response to the emergence of Japanese encephalitis virus (JEV) in New South Wales. The nature of a rapid public health response, which is focused on understanding enough to contain the risk in a short space of time, inherently limits the comprehensiveness of the epidemiological design.


  • Health Protection NSW, NSW Health, Government of NSW, St Leonards, NSW



Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.